CONMED CORPORATION Amortization of Debt Issuance Costs
CONMED CORPORATION (CNMD) reported Amortization of Debt Issuance Costs of $2.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-07-29
- CONMED CORPORATION amortization of debt issuance costs for the quarter ending 2025-12-31 was $1.54M, a 6.58% increase year-over-year.
- CONMED CORPORATION amortization of debt issuance costs for the quarter ending 2025-09-30 was $1.28M, a 11.57% decline year-over-year.
- CONMED CORPORATION amortization of debt issuance costs for the quarter ending 2025-06-30 was $1.39M, a 1.28% decline year-over-year.
- CONMED CORPORATION amortization of debt issuance costs for the quarter ending 2025-03-31 was $1.44M, a 2.56% increase year-over-year.
- CONMED CORPORATION amortization of debt issuance costs for fiscal 2025 was $5.65M, a 0.95% decline from fiscal 2024.
- CONMED CORPORATION amortization of debt issuance costs for fiscal 2024 was $5.70M, a 5.91% decline from fiscal 2023.
- CONMED CORPORATION amortization of debt issuance costs for fiscal 2023 was $6.06M, a 23.38% increase from fiscal 2022.
- CONMED CORPORATION amortization of debt issuance costs for fiscal 2022 was $4.91M, a 31.78% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.33M 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.81M derived: sum of 2 quarters · filed 2026-02-17 | $4.20M derived: sum of 3 quarters · filed 2026-07-29 | $5.65M 10-K · filed 2026-02-17 |
| 2025-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.66M derived: sum of 2 quarters · filed 2026-07-29 | $4.11M 10-Q · filed 2025-11-06 | $5.55M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.83M 10-Q · filed 2026-07-29 | $4.28M derived: sum of 3 quarters · filed 2026-07-29 | $5.72M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.44M 10-Q · filed 2025-05-01 | $2.89M derived: sum of 2 quarters · filed 2026-02-17 | $4.33M derived: sum of 3 quarters · filed 2026-02-17 | $5.74M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.89M derived: sum of 2 quarters · filed 2026-02-17 | $4.29M derived: sum of 3 quarters · filed 2026-02-17 | $5.70M 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.85M derived: sum of 2 quarters · filed 2025-11-06 | $4.26M 10-Q · filed 2025-11-06 | $5.76M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.81M 10-Q · filed 2025-07-31 | $4.31M derived: sum of 3 quarters · filed 2026-02-17 | $5.86M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.41M 10-Q · filed 2025-05-01 | $2.91M derived: sum of 2 quarters · filed 2026-02-17 | $4.45M derived: sum of 3 quarters · filed 2026-02-17 | $5.96M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $3.05M derived: sum of 2 quarters · filed 2026-02-17 | $4.55M derived: sum of 3 quarters · filed 2026-02-17 | $6.06M 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $3.05M derived: sum of 2 quarters · filed 2024-10-31 | $4.56M 10-Q · filed 2024-10-31 | $6.06M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.01M 10-Q · filed 2024-08-01 | $4.52M derived: sum of 3 quarters · filed 2025-02-18 | $6.01M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.51M 10-Q · filed 2024-04-25 | $3.01M derived: sum of 2 quarters · filed 2025-02-18 | $4.50M derived: sum of 3 quarters · filed 2025-02-18 | $5.54M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $2.99M derived: sum of 2 quarters · filed 2025-02-18 | $4.03M derived: sum of 3 quarters · filed 2025-02-18 | $4.91M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $2.52M derived: sum of 2 quarters · filed 2023-10-26 | $3.40M 10-Q · filed 2023-10-26 | $4.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $1.92M 10-Q · filed 2023-07-27 | $2.70M derived: sum of 3 quarters · filed 2024-02-28 | $3.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $880.00K 10-Q · filed 2023-04-27 | $1.66M derived: sum of 2 quarters · filed 2024-02-28 | $2.49M derived: sum of 3 quarters · filed 2024-02-28 | $3.55M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.61M derived: sum of 2 quarters · filed 2024-02-28 | $2.67M derived: sum of 3 quarters · filed 2024-02-28 | $3.73M 10-K · filed 2024-02-28 |
| 2021-09-30 | $830.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $1.89M derived: sum of 2 quarters · filed 2022-10-27 | $2.95M 10-Q · filed 2022-10-27 | $3.97M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $2.12M 10-Q · filed 2022-07-28 | $3.14M derived: sum of 3 quarters · filed 2023-02-21 | $4.15M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $1.06M 10-Q · filed 2022-05-05 | $2.08M derived: sum of 2 quarters · filed 2023-02-21 | $3.10M derived: sum of 3 quarters · filed 2023-02-21 | $3.96M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $2.04M derived: sum of 2 quarters · filed 2023-02-21 | $2.90M derived: sum of 3 quarters · filed 2023-02-21 | $3.72M 10-K · filed 2023-02-21 |
| 2020-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.88M derived: sum of 2 quarters · filed 2021-10-28 | $2.70M 10-Q · filed 2021-10-28 | $3.62M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $1.69M 10-Q · filed 2021-07-29 | $2.60M derived: sum of 3 quarters · filed 2022-02-22 | $3.52M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $819.00K 10-Q · filed 2021-04-29 | $1.74M derived: sum of 2 quarters · filed 2022-02-22 | $2.66M derived: sum of 3 quarters · filed 2022-02-22 | $3.58M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.84M derived: sum of 2 quarters · filed 2022-02-22 | $2.76M derived: sum of 3 quarters · filed 2022-02-22 | $3.45M 10-K · filed 2022-02-22 |
| 2019-09-30 | $919.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.84M derived: sum of 2 quarters · filed 2020-10-29 | $2.54M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $1.62M 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $697.00K 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | $1.04M 10-K · filed 2021-02-22 | |||
| 2017-12-31 | $1.04M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |